|
World Vaccine Congress Asia 2009将吸引来自全球及区域性之疫苗交易业者、管理机关、投资家、技术．服务业者齐聚，共同探讨亚洲各种疫苗市场之商业策略，在此将有机会可以找寻国际化所需之战略合作伙伴。
从15个亚洲机构来了解次世代革新疫苖的最新发展动向。
在此将介绍亚洲制药企业、生技企业、以及大学之最新疫苗开发、技术革新动向。
将有机会与亚洲10个国家以上的买家进行商谈。
国际公共卫生领导人士、疾病管制当局、及管理机关齐聚，将为他们的市场判定所需之疫苗。
更新经营战略：向亚洲排名前20之市场领导者学习。
听取业界专家针对亚洲疫苗市场所制定之『蓝海战略』。
与疫苗买家之交流
Sanofi Pasteur, Novartis, Intercell, Indian Immunologicals, GlaxoSmithKline Biologicals, Green Cross, China National Biotec Group (CNBG), Crucell, Shantha Biotech等企业将莅临会议。
» Reserve your seat now
|
Are we pandemic ready? Find out at the Influenza Vaccine Summit!
The H1N1 (swine flu) has reached the shores of Asia. This is the first time the WHO had declared a Phase 5 outbreak, the second-highest on its threat scale, indicating a pandemic could be “imminent”. To date, it remains probable that the alert level would be raised from its current level of 5 to the top of the six-stage scale.
Stockpiling of anti-flu drugs is the top most priority of Asian health ministers as they prepare for the possible outbreak of H1N1 in the region. The main concerns are ― whether the current stockpile is enough for the region and how quickly a vaccine can be produced in the event of an outbreak.
Join us at World Vaccine Congress Asia’s Influenza Vaccine Summit, a summit dedicated to tackle the latest developments in influenza. The program will discuss topics that include preparing for a pandemic, the seasonal flu, technologies for scale up production and many more. Leading players such as Sanofi Pasteur, GSK, CSL will participate in the summit, giving you an unprecedented opportunity to knowledge-share during these critical times.
» View the Influenza Vaccine Summit agenda
|
